Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001615219-25-000037
Filing Date
2025-03-21
Accepted
2025-03-21 16:30:49
Documents
68
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K flks-20241231.htm   iXBRL 10-K 1118963
2 EX-10.25 amendment1davidarthurconsu.htm EX-10.25 85095
3 EX-19.1 attachmentf_salarius-insid.htm EX-19.1 59375
4 EX-23.1 eyconsent.htm EX-23.1 6937
5 EX-31.1 slrx20241231ex-311.htm EX-31.1 10709
6 EX-31.2 slrx12312024-312expfocerti.htm EX-31.2 10715
7 EX-32.1 slrx12312024-321ex906peoce.htm EX-32.1 5541
8 EX-32.2 slrx12312024-322ex906pfoce.htm EX-32.2 5418
14 image.jpg GRAPHIC 12338
15 image_2.jpg GRAPHIC 238618
16 screenshot2025-03x21122544.jpg GRAPHIC 2305
  Complete submission text file 0001615219-25-000037.txt   5180825

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20241231.xsd EX-101.SCH 28293
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20241231_cal.xml EX-101.CAL 33096
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20241231_def.xml EX-101.DEF 113450
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20241231_lab.xml EX-101.LAB 453992
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20241231_pre.xml EX-101.PRE 299192
71 EXTRACTED XBRL INSTANCE DOCUMENT flks-20241231_htm.xml XML 354389
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36812 | Film No.: 25760969
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)